The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Sodium Di‐N‐Propylacetate (DPA) in the Treatment of Epilepsy:A Review
Abstract
SUMMARY: The literature on clinical and expérimentalstudies of sodium dipropylacetate (DPA), a branched chain carboxylic acid with a unique antiepileptic structure, is critically reviewed. The clinical antiepileptic properties are evaluated by seizure type. DPA appears to be most efficacious in the treatment of absence seizures. The literature also provides evidence for efficacy in the treatment of generalized tonic‐clonic seizures and partial seizures with elementary symptomatology. The clinical pharmacology of DPA has not been thoroughly investigated. Simple, accurate, and reproducible gas‐liquid chromatographic methods are available for determining the concentration of DPA in body tissues and fluids. The plasma half‐life in humans is 8 to 15 hr. The most frequently observed adverse effects are gastrointestinal disturbances. In patients receiving additional antiepileptic drugs, potentially serious sedative effects have also been noted, which may be due to an interaction between DPA and concurrently administered medications. RÉSUMÉ: On fait une revue critique des études cliniques et expe'rimentales du sodium dipropyl‐acetate (DPA), un acide carboxylique avec une structure anti‐épileptique unique. Les propriétés cliniques antiepileptiques sont évaluées selon le type de crise. DPA semble être plus efficace dans le traitement des absences. La literature démontre aussi son efficacite 1 dans le traitement des crises tonico‐cloniques generalised et dans les crises partielles avec une symptomatologie elementaire. Les proprieties pharmacologiques cliniques du DPA n'ont pas et6 entierement étudiées. On dispose actuelle‐ment de methodes simples, precises et repro‐ductibles de chromatographie en phase liquide et gazeuse pour determiner la concentration de DPA dans les tissus et les liquides de l'organisme humain. La demi‐vie plasmatique chez lliomme est de 8 a 15 heures. Les effets secondaires observes le plus souvent sont des troubles gastroiritestinaux. Des effets sedatifs tres importants, peuvent aussi être observes chez des malades recevant en meme temps un traitement antiepileptique; ces effets peuvent être dfis a une interaction entre le DPA et les autres medicaments associés. RESUMEN: Se ha realizado una revision critica de las publicaciones de estudios cli'nicos y experi‐mentales del dipropilacetato sodico (DPA), un acido carboxilico con cadena ramificada y con una estructura especificamente antiepileptica. Las propiedades antiepilepticas se valoraron segun el tipo de ataque. DPA parece ser mas eficaz en el tratamien‐to de las ausencias. La literatura tambien produce evidencia respecto a la eficacia en el tratamiento de ataques generalizados clonico‐tonicos y en los focales con sintomatologfa elemental. La farmacologia chnica del DPA todavia no ha sido suficientemente investigada. Actualmente se dispone de simples me'todos de cromatografia de gases‐li'quidos, fiables y reproducibles, para determinar la concentration de DPA en tejidos y fluidos del cuerpo humano. La vida media en plasma humano es de 18 a 15 horas. Los transtornos gastrointestinales son los mas frecuentes signos de intolerancia. La posi‐bilidad de sedacion importante ha sido tam‐bi6n observada en enfermos que reciben otros antiepilepticos, probablemente debida a una interaction entre el DPA y las medicaciones administradas simultaneamente. ZUSAMMENFASSUNG: Kritische übersicht über die Literatur der klinischen und experimentellen Untersuchun‐gen mit Natrium Dipropylacetat (DPA), einer verzweigtkettigen Carboxylsaure, die eine Struktur hat, die fur Antikonvulsiva ungewöhnlich ist. Die klinischen antiepileptischen Eigenschaften gegentiber verschiedenen Anfall‐stypen wurden bestimmt. DPA scheint besonders wirksam in der Behandlung der Absencen zu sein. Die Literatur kennt auch Hinweise für die Wirksamkeit in der Behandlung der generalisierten tonisch‐klonischen Krampfe und partieller Anfalle ele‐mentarer Symptomatologie. Die klinische Pharmakologie des DPA ist nicht grundlich untersucht worden. Einfache, akkurate und reproduzierbare gaschromatog‐raphische Methoden zur Bestimmung der Kon‐zentration des DPA im Korpergewebe und Flussigkeiten stehen zur Verfiigung. Die Plas‐mahalbwertszeit bei Menschen betragt 8–15 Stunden. Die am haufigsten beobachteten ungiinsti‐gen Nebenwirkungen betreffen gastrointes‐tinale Storungen. Bei Patienten mit zusatz‐licher antiepileptischer Therapie wurden gele‐gentlich schwerwiegende sedative Effekte beobachtet, die moglicherweise Folge der Interak‐tion zwischen DPA und anderen gleichzeitig verabfolgten Medikamenten sind.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychopharmacology. A Review of Progress, 1957-1967
Burger, A. (1969) · Journal of Medicinal Chemistry · doi:10.1021/jm00305a903 · Cited by 891
Clinical and Electroencephalographical Classification of Epileptic Seizures
Gastaut, H. (1970) · Epilepsia · doi:10.1111/j.1528-1157.1970.tb03871.x · Cited by 557
Inhibition in the nervous system and gamma-aminobutyric acid
Blaschko, H. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90143-5 · Cited by 410
Biochemical-physiology correlations in studies of the γ-aminobutyric acid system
Roberts, E., & Kuriyama, K. (1968) · Brain Research · doi:10.1016/0006-8993(68)90170-4 · Cited by 409
EFFECTS OF DI‐n‐PROPYLACETATE, AN ANTICONVULSIVE COMPOUND, ON GABA METABOLISM1
Godin, Y., Heiner, L., Mark, J., & Mandel, P. (1969) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1969.tb08975.x · Cited by 398
Psychotropic Drugs and Related Compounds.
Burger, A. (1967) · Journal of Medicinal Chemistry · doi:10.1021/jm00318a063 · Cited by 279
[Pharmacodynamic properties of N-dipropylacetic acid].
Meunier, H., Carraz, G., Neunier, Y., Eymard, P., & Aimard, M. (1963) · PubMed · Cited by 251
ANTICONVULSANT PROPERTIES OF SOME BENZODIAZEPINES
Swinyard, E. A., & Castellion, A. W. (1966) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27268-8 · Cited by 117
Effects of Carbon Dioxide on Brain Excitability and Electrolytes
Woodbury, D. M., Rollins, L. T., Gardner, M. D., Hirschi, W. L., Hogan, J. R., Rallison, M. L., Tanner, G. S., & Brodie, D. A. (1957) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1957.192.1.79 · Cited by 114
Matsumoto, I., Kuhara, T., & Yoshino, M. (1976) · Journal of Mass Spectrometry · doi:10.1002/bms.1200030509 · Cited by 64
Cited by
Migraine Prophylaxis With Divalproex
Mathew, N. T., Saper, J. R., Silberstein, S. D., Rankin, L., Markley, H. G., Solomon, S., Rapoport, A. M., Silber, C. J., & Deaton, R. L. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540270077022 · Cited by 329
Sodium Valproate: A Review of its Pharmacological Properties and Therapeutic Efficacy in Epilepsy
Pinder, R. M., Brogden, R. N., Speight, T. M., & Avery, G. S. (1977) · Drugs · doi:10.2165/00003495-197713020-00001 · Cited by 315
Sodium Valproate: Monotherapy and Polytherapy
Covanis, A., Gupta, A. K., & Jeavons, P. M. (1982) · Epilepsia · doi:10.1111/j.1528-1157.1982.tb05085.x · Cited by 284
Pinder (1976) · doi:10.2165/00003495-197612050-00001 · Cited by 111
Effects of sodium valproate on development and social behaviour in the Mongolian gerbil
Chapman, J. B., & Cutler, M. G. (1989) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(89)90058-5 · Cited by 14
Metadata
- Authors
- Simon, D., & Penry, J. K.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 1975-11
- Volume
- 16
- Issue
- 4
- Pages
- 549-573
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W1978173138
- Cited by
- 252
- References
- 12
- FWCI
- 22.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sodium Di‐N‐Propylacetate (DPA) in the Treatment of Epilepsy:A Review. https://app.cochat.ai/papers/10.1111/j.1528-1157.1975.tb04738.x
- The paper
- Simon, D., & Penry, J. K. (1975). Sodium Di‐N‐Propylacetate (DPA) in the Treatment of Epilepsy:A Review. Epilepsia. https://doi.org/10.1111/j.1528-1157.1975.tb04738.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.